Exelixis
EXEL
#1780
Rank
A$15.09 B
Marketcap
$52.86
Share price
1.10%
Change (1 day)
59.72%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $78.98 AUD on 2000-07-26

Lowest end of day price: $2.07 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$56.23-0.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
$83.64-1.55%๐Ÿ‡ซ๐Ÿ‡ท France
$157.62 0.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$94.70 0.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$451.74 0.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$242.41 0.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$42.69-0.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.16 2.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.06 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA